Extendicare (EXE) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 Nov, 2025Executive summary
Q3 2025 delivered strong organic growth and a full quarter impact from recent acquisitions, including the $75.1 million Closing the Gap deal, which added 1,200 caregivers, 1.1 million annual service hours, and exceeded revenue and NOI expectations.
Margin improvements were seen across all segments, with home healthcare volumes at ParaMed rising 13% year-over-year, the largest organic growth to date, driven by demographic trends and capacity constraints in long-term care.
Strategic M&A, operational execution, and disciplined capital allocation underpinned performance, with targeted annualized cost synergies of $1.1 million from the Closing the Gap acquisition.
Adjusted EBITDA, excluding out-of-period items, rose 36.6% year-over-year to $46.9 million.
AFFO per share (basic), excluding out-of-period items, increased 19.3% year-over-year to $0.309.
Financial highlights
Q3 2025 revenue was $440.3 million, up 22.6% year-over-year, driven by acquisitions and organic growth.
Adjusted EBITDA reached $50.8 million, a 40.6% increase year-over-year.
Net earnings were $24.1 million, up 48.0% from the prior year.
Q3 NOI improved to $65.9 million, up 31.5%, with acquisitions contributing $6.3 million.
Home healthcare revenue grew 35% year-over-year, with NOI up 63.2%.
Outlook and guidance
Ongoing demographic trends and long-term care waitlists are expected to sustain demand for home healthcare, with no meaningful decline in waitlists projected for the next few years.
The company remains focused on scalable growth, with flexibility to pursue further acquisitions and is advancing 18 redevelopment projects under Ontario’s new LTC Home Capital Funding Policy.
Six LTC homes under construction, replacing 1,097 Class C beds with 1,408 new beds.
Breaking ground on a new home in Sudbury in Q4 2025, with three new homes opened since Q1 2024.
Anticipates $1.1 million in annualized cost synergies from the Closing the Gap acquisition in the first year.
Latest events from Extendicare
- Strong 2025 growth, 5% dividend hike, and $570M CBI Home Health deal closing in Q2 2026.EXE
Q4 202527 Feb 2026 - Q2 2024 delivered strong revenue, margin growth, and robust progress in redevelopment.EXE
Q2 20241 Feb 2026 - Double-digit revenue and margin growth, with enhanced liquidity and redevelopment progress.EXE
Q3 202414 Jan 2026 - Q4 2024 saw strong growth, margin gains, and a 5% dividend hike amid robust demand.EXE
Q4 20241 Dec 2025 - All proposals passed, with a 5% dividend hike and major growth and governance initiatives.EXE
AGM 202526 Nov 2025 - Q1 growth, margin gains, and acquisitions drive momentum amid strong sector demand.EXE
Q1 202526 Nov 2025 - Q2 2025 delivered 15.4% EBITDA growth and expansion from major acquisitions and home health care.EXE
Q2 202523 Nov 2025 - $570M deal creates Canada’s largest home health care platform, driving growth and efficiency.EXE
M&A Announcement20 Nov 2025 - Strong growth, acquisitions, and stable government funding drive expansion in seniors' care.EXE
Investor Presentation25 Aug 2025